PATH
Seattle, Washington, United States
Purpose
to identify species-conserved Group B Streptococcus proteins to be used as carrier proteins in the low-cost hexavalent GBS conjugate vaccine under development at Biovac
Division
Global Health
Date
November 2018
Region Served
GLOBAL
Committed amount
$2,746,638
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
73
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.